Thoughts on blood testing and analysis of results by medical student and T1 diabetic Matthew Anson. The management of diabetes is, in its purest form,
Last year, we interviewed semi-pro tennis player Josh Golding and he has been in touch to talk to use about his progress with tennis and
Entries for the Quality in Care Awards 2019 are now open. The deadline for submitting nominations is 31 May. If you know of someone who’s
Within the next six months, Animas users need to be transitioned onto another pump of their choice. As previously advised, Animas’ goal is to transition
The European Commission (EC) has approved Forxiga (dapagliflozin) for use in Type 1 diabetes (T1D) as an adjunct to insulin in patients with a BMI
Type 1 diabetic Rob Brown has set off for Morocco where he is taking part in the Marathon des Sables, a 150-mile footrace across the
Novo Nordisk UK has announced that Ozempic (semaglutide), a new once-weekly GLP-1 analogue injection for the treatment of Type 2 diabetes is now available in
One in ten people over 40 in the UK is now living with a diagnosis of Type 2 diabetes, according to new analysis released by
Marking the start of NHS England’s Type 2 Diabetes Prevention Week, Diabetes UK has released new analysis which shows that one person is diagnosed with
The administrators appointed at Cellnovo Ltd., the Cellnovo Group (“Cellnovo” or the “Company”)’s UK subsidiary, have concluded an initial analysis and have actioned a restructuring
